Publications

Spatial Signatures Identify Immune Escape via PD-1 as a Defining Feature of T-cell/Histiocyte-rich Large B-cell Lymphoma

Griffin, G. K., Weirather, J. L., Roemer, M., Lipschitz, M., Kelley, A., Chen, P. H., Gusenleitner, D., Jeter, E., Pak, C., Gjini, E., Chapuy, B., Rosenthal, M. H., Xu, J., Chen, B. J., Sohani, A. R., Lovitch, S. B., Abramson, J. S., Ishizuka, J. J., Kim, A. I., Jacobson, C. A., … Rodig, S. J. (2021). Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma. Blood, 137(10), 1353–1364. https://doi.org/10.1182/blood.2020006464

Spatial Signatures Identify Immune Escape via PD-1 as a Defining Feature of T-cell/Histiocyte-rich Large B-cell Lymphoma Read More »

Multispectral Imaging Enables Characterization of Intrahepatic Macrophages in Patients With Chronic Liver Disease

Saldarriaga, O. A., Freiberg, B., Krishnan, S., Rao, A., Burks, J., Booth, A. L., … & Yi, M. (2020). Multispectral Imaging Enables Characterization of Intrahepatic Macrophages in Patients With Chronic Liver Disease. Hepatology Communications, 4(5), 708-723.

Multispectral Imaging Enables Characterization of Intrahepatic Macrophages in Patients With Chronic Liver Disease Read More »

Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment and identifies a combination biomarker for primary melanoma

Gartrell-Corrado, R. D., Chen, A. X., Rizk, E. M., Marks, D. K., Bogardus, M. H., Hart, T. D., … & Komatsubara, K. M. (2020). Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment and identifies a combination biomarker for primary melanoma. Cancer Research, 80(5), 1078-1087.

Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment and identifies a combination biomarker for primary melanoma Read More »

Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab

Minchom, A., Yuan, W., Crespo, M., Gurel, B., Figueiredo, I., Wotherspoon, A., … & Pereira, R. (2020). Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab. Journal for immunotherapy of cancer, 8(1).

Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab Read More »

Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination

van Beek, J., Flórez-Grau, G., Gorris, M., Mathan, T., Schreibelt, G., Bol, K. F., Textor, J., & de Vries, I. (2020). Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination. Cell reports, 30(4), 1027–1038.e4. https://doi.org/10.1016/j.celrep.2019.12.096

Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination Read More »

Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

Bhatia, S., Longino, N. V., Miller, N. J., Kulikauskas, R., Iyer, J. G., Ibrani, D., … & Campbell, J. S. (2020). Clinical Cancer Research, 26(3), 598-607. PMID: 31582519 DOI: 10.1158/1078-0432.CCR-19-0972

Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma Read More »

Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy

De Angelis, C., Nagi, C., Hoyt, C. C., Liu, L., Roman, K., Wang, C., … & Wang, T. (2020). Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy. Clinical Cancer Research, 26(3), 738-745.

Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy Read More »

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

Cillo, A. R., Kürten, C., Tabib, T., Qi, Z., Onkar, S., Wang, T., Liu, A., Duvvuri, U., Kim, S., Soose, R. J., Oesterreich, S., Chen, W., Lafyatis, R., Bruno, T. C., Ferris, R. L., & Vignali, D. (2020). Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer. Immunity, 52(1), 183–199.e9. https://doi.org/10.1016/j.immuni.2019.11.014

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer Read More »